Metabolic reprogramming of clear cell renal cell carcinoma
Authors:
Top Cited Papers
Open Access
- 6 June 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1195500
Abstract
Clear cell renal cell carcinoma (ccRCC) is a malignancy that exhibits metabolic reprogramming as a result of genetic mutations. This reprogramming accommodates the energy and anabolic needs of the cancer cells, leading to changes in glucose, lipid, and bio-oxidative metabolism, and in some cases, the amino acid metabolism. Recent evidence suggests that ccRCC may be classified as a metabolic disease. The metabolic alterations provide potential targets for novel therapeutic interventions or biomarkers for monitoring tumor growth and prognosis. This literature review summarized recent discoveries of metabolic alterations in ccRCC, including changes in glucose, lipid, and amino acid metabolism. The development of metabolic drugs targeting these metabolic pathways was also discussed, such as HIF-2α inhibitors, fatty acid synthase (FAS) inhibitors, glutaminase (GLS) inhibitors, indoleamine 2,3-dioxygenase (IDO) inhibitors, and arginine depletion. Future trends in drug development are proposed, including the use of combination therapies and personalized medicine approaches. In conclusion, this review provides a comprehensive overview of the metabolic alterations in ccRCC and highlights the potential for developing new treatments for this disease.Keywords
This publication has 116 references indexed in Scilit:
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- A complex task? Direct modulation of transcription factors with small moleculesCurrent Opinion in Chemical Biology, 2010
- Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt SignalingCancer Research, 2009
- Grade-dependent Proteomics Characterization of Kidney CancerMolecular & Cellular Proteomics, 2009
- Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivationBiochemical Journal, 2009
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- On the Origin of Cancer CellsScience, 1956